NYSE
$7.40▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $91.6MShares out 12.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
22- 10.14After-hours26.10.15 06:008-KKey event#●●●#●●●
Neuraxis, INC
Neuraxis, Inc. has declared a third-quarter dividend for its Series B Preferred Stock, which will be paid in shares of common stock. Approximately 81,339 shares of common stock will be issued at a value of $2.38 per share, with a payment date of October 30, 2026.…more
$7.40+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8After-hours26.10.09 06:504Ownership
Neuraxis, INC
Neuraxis executive Brian Allen Carrico reported a change in beneficial ownership of securities via a Form 4 filing on October 8, 2026. This filing reflects a change in the insider's equity holdings, providing investors with updated information regarding management's stake.…more
$7.40+0.00%vs prev closeView filingShare - 10.8After-hours26.10.09 06:474Ownership
Neuraxis, INC
Insider Thomas Joeseph Carrico of Neuraxis, INC reported a change in beneficial ownership of securities on October 8, 2026. This Form 4 filing discloses the insider's transaction details, with specific share counts and pricing available in the accompanying documentation.…more
$7.40+0.00%vs prev closeView filingShare
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15Pre-market26.10.15 22:18#●●●#●●●
NeurAxis Expands Insurance Coverage for IB-Stim to 26 Million Additional Lives…more
NeurAxis has secured new medical policy coverage from a major national insurer, increasing its total footprint to over 147 million covered lives. While this expansion is expected to drive future revenue growth and market adoption, actual financial impact remains to be seen.…more
$7.40+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.29Pre-market26.09.29 20:00
●●●●●●●● ●●●●● ●●●●●●
NeurAxis has appointed Craig Blanchard as its new Chief Commercial Officer to lead its commercial operations. This strategic hire aims to support the expansion of the company's sales organization and drive broader adoption of its IB-Stim technology.…more
$7.40+0.00%vs prev close - 9.16Pre-market26.09.16 22:02
●●●●●●●● ●●●●● ●●●●●●
NeurAxis has secured medical policy coverage for its PENFS treatment from an unnamed national health insurer. While this expansion is expected to improve patient access, the company did not disclose specific financial terms or the impact of the agreement.…more
$7.40+0.00%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report